Fast Track Discovery Program

When it comes to access to oncology drugs, cancer patients can't wait. That's why making quick decisions about early candidates is vital to providing life-changing drugs faster.

Save 4 weeks on your screening, proof of concept or simple combination studies with our fast track program. Leverage our pre-determined battery of models and studies to experience accelerated timelines while relying on the same high quality scientific engagement and collaboration you have come to depend on from our highly trained team members.

Program qualifiers

To reach top speed efficiently, the following criteria must be met to qualify for our fast track program:

• Compound must be in-house, ready for near-immediate shipment
  • If material needs to be pathogen tested, the scientific development team will provide guidance as to where samples must be sent
• Select from our preapproved subcutaneous or orthotopic mammary fat pad models
• Study design cannot exceed 80 mice on study
  • Maximum treatment window: 35 days
  • Total in-life duration: 60 days
• Up to six survival and/or terminal blood sampling time points are allowed and up to three tissue collections at termination
• No imaging or radiation treatment is allowed
• Bioanalysis may be offered as a separate agreement
• Significant changes to the protocol may result in change fees and timeline delays